Table 2.

Summary of biochemical response rates in the extension study for patients who entered the extension (N = 88).

	Patients, n (%) [95% CI]
	Week 36*	Week 48	Week 60	Week 72
mGH <1.0 μg/L and IGF-I <ULN	13 (14.8) [8.1–23.9]	11 (12.5) [6.4–21.3]	13 (14.8) [8.1–23.9]	10 (11.4) [5.6–19.9]
mGH <1.0 μg/L	19 (21.6) [13.5–31.7]	21 (23.9) [15.4–34.1]	19 (21.6) [13.5–31.7]	18 (20.5) [12.6–30.4]
IGF-I <ULN	30 (34.1) [24.3–45.0]	29 (33.0) [23.3–43.8]	33 (37.5) [27.4–48.5]	29 (33.0) [23.3–43.8]

^*End of core study/extension baseline.